| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 65, 724-731, Copyright © 1987 by Endocrine Society
ARTICLES |
DB Endres, CH Morgan, PJ Garry and JL Omdahl
Department of Pathology, University of Southern California School of Medicine, Los Angeles 90033.
Circulating levels of PTH and related parameters of calcium and phosphate metabolism were measured in healthy free-living elderly and young subjects residing in the Southwest to determine if parathyroid function changes with aging. Serum immunoreactive PTH (iPTH) was measured with two well characterized antisera; an amino (N)-terminal antiserum which cross-reacts with the biologically active domain (1-34) and recognizes intact hormone, and a midregion (44-68) antiserum which cross-reacts with intact hormone and biologically inactive midregion/C- terminal fragments. Serum iPTH in both RIAs was significantly increased in the elderly population. An age-related increase was also found for total urinary cAMP and serum alkaline phosphatase, whereas the tubular reabsorptive maximum for phosphate (TmP/GFR) decreased with age. No difference was found between men and women of the same age group for serum iPTH, urinary cAMP, or serum alkaline phosphatase. TmP/GFR declined with age in men, but not women. Correspondingly, serum phosphate was significantly lower in elderly men than in elderly women. Urinary calcium excretion was higher in elderly women than in men of the same age group. Neither serum total or ionized calcium decreased with age. In conclusion, the age-related increase in N-terminal PTH and alterations in associated parameters of phosphate and calcium metabolism are consistent with increased parathyroid function as men and women age. Factors other than PTH are responsible for the sex- related differences observed in TmP/GFR, calcium excretion, and serum phosphate. The cause of the increased circulating levels of apparently biologically active PTH is unclear, but extends beyond the age-related decrease in renal function.
This article has been cited by other articles:
![]() |
H. D. White, A. M. Ahmad, B. H. Durham, S. Chandran, A. Patwala, W. D. Fraser, and J. P. Vora Effect of Active Acromegaly and Its Treatment on Parathyroid Circadian Rhythmicity and Parathyroid Target-Organ Sensitivity J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 913 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Maimoun, D Simar, D Malatesta, C Caillaud, E Peruchon, I Couret, M Rossi, and D Mariano-Goulart Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects Br. J. Sports Med., August 1, 2005; 39(8): 497 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Carnevale, S. Dionisi, I. Nofroni, E. Romagnoli, F. Paglia, S. De Geronimo, J. Pepe, G. Clemente, G. Tonnarini, and S. Minisola Potential Clinical Utility of a New IRMA for Parathyroid Hormone in Postmenopausal Patients with Primary Hyperparathyroidism Clin. Chem., March 1, 2004; 50(3): 626 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatayerji, E. B. Mawer, and R. Eastell The Role of Insulin-Like Growth Factor I in Age-Related Changes in Calcium Homeostasis in Men J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4657 - 4662. [Abstract] [Full Text] |
||||
![]() |
A. G Need, M. Horowitz, H. A Morris, and B. C. Nordin Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1577 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Perry III The Endocrinology of Aging Clin. Chem., August 1, 1999; 45(8): 1369 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. FELSENFELD and M. RODRIGUEZ Phosphorus, Regulation of Plasma Calcium, and Secondary Hyperparathyroidism: A Hypothesis to Integrate a Historical and ModernPerspective J. Am. Soc. Nephrol., April 1, 1999; 10(4): 878 - 890. [Full Text] |
||||
![]() |
S. Jono, Y. Nishizawa, A. Shioi, and H. Morii 1,25-Dihydroxyvitamin D3 Increases In Vitro Vascular Calcification by Modulating Secretion of Endogenous Parathyroid Hormone–Related Peptide Circulation, September 29, 1998; 98(13): 1302 - 1306. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |